Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings

Michael M. Ward, Deborah Lubeck, J Paul Leigh

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective. To compare health care utilization and longterm health outcomes among patients with rheumatoid arthritis (RA) treated in managed care and fee-for-service practice settings. Methods. We compared levels of health care utilization, treatments, and health outcomes between 57 patients with RA treated predominantly in managed care settings and 125 patients with RA treated predominantly in fee-for-service practice settings. These patients were participants in a community based cohort study of health outcomes in RA, and had been followed prospectively for up to 13 years (mean follow-up 10.3 yrs). Information on physician visits, hospitalizations, diagnostic testing, treatments, and 3 measures of health status (global arthritis status, pain, functional disability measures of the Health Assessment Questionnaire) was collected using biannual mailed questionnaires. Results. All measures of health care utilization were similar between the managed care and fee-for- service groups, as was the use of the major types of arthritis treatments. Average global arthritis status scores, pain scores, and functional disability scores were closely comparable in the 2 groups. Over time, global arthritis status scores and disability scores worsened in both groups, but the rates of worsening did not differ between groups. Conclusion. In this cohort, longterm health outcomes, as well as treatments and health care utilization, were similar among persons with RA who were treated in managed care and fee-for-service practice settings.

Original languageEnglish (US)
Pages (from-to)641-649
Number of pages9
JournalJournal of Rheumatology
Volume25
Issue number4
StatePublished - Apr 1998
Externally publishedYes

Fingerprint

Fee-for-Service Plans
Patient Acceptance of Health Care
Managed Care Programs
Rheumatoid Arthritis
Arthritis
Health
Health Status
Pain
Hospitalization
Cohort Studies
Therapeutics
Physicians

Keywords

  • Managed care
  • Quality of care
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. / Ward, Michael M.; Lubeck, Deborah; Leigh, J Paul.

In: Journal of Rheumatology, Vol. 25, No. 4, 04.1998, p. 641-649.

Research output: Contribution to journalArticle

@article{d166a49fc2414f1b86b74a40f6312a11,
title = "Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings",
abstract = "Objective. To compare health care utilization and longterm health outcomes among patients with rheumatoid arthritis (RA) treated in managed care and fee-for-service practice settings. Methods. We compared levels of health care utilization, treatments, and health outcomes between 57 patients with RA treated predominantly in managed care settings and 125 patients with RA treated predominantly in fee-for-service practice settings. These patients were participants in a community based cohort study of health outcomes in RA, and had been followed prospectively for up to 13 years (mean follow-up 10.3 yrs). Information on physician visits, hospitalizations, diagnostic testing, treatments, and 3 measures of health status (global arthritis status, pain, functional disability measures of the Health Assessment Questionnaire) was collected using biannual mailed questionnaires. Results. All measures of health care utilization were similar between the managed care and fee-for- service groups, as was the use of the major types of arthritis treatments. Average global arthritis status scores, pain scores, and functional disability scores were closely comparable in the 2 groups. Over time, global arthritis status scores and disability scores worsened in both groups, but the rates of worsening did not differ between groups. Conclusion. In this cohort, longterm health outcomes, as well as treatments and health care utilization, were similar among persons with RA who were treated in managed care and fee-for-service practice settings.",
keywords = "Managed care, Quality of care, Rheumatoid arthritis",
author = "Ward, {Michael M.} and Deborah Lubeck and Leigh, {J Paul}",
year = "1998",
month = "4",
language = "English (US)",
volume = "25",
pages = "641--649",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "4",

}

TY - JOUR

T1 - Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings

AU - Ward, Michael M.

AU - Lubeck, Deborah

AU - Leigh, J Paul

PY - 1998/4

Y1 - 1998/4

N2 - Objective. To compare health care utilization and longterm health outcomes among patients with rheumatoid arthritis (RA) treated in managed care and fee-for-service practice settings. Methods. We compared levels of health care utilization, treatments, and health outcomes between 57 patients with RA treated predominantly in managed care settings and 125 patients with RA treated predominantly in fee-for-service practice settings. These patients were participants in a community based cohort study of health outcomes in RA, and had been followed prospectively for up to 13 years (mean follow-up 10.3 yrs). Information on physician visits, hospitalizations, diagnostic testing, treatments, and 3 measures of health status (global arthritis status, pain, functional disability measures of the Health Assessment Questionnaire) was collected using biannual mailed questionnaires. Results. All measures of health care utilization were similar between the managed care and fee-for- service groups, as was the use of the major types of arthritis treatments. Average global arthritis status scores, pain scores, and functional disability scores were closely comparable in the 2 groups. Over time, global arthritis status scores and disability scores worsened in both groups, but the rates of worsening did not differ between groups. Conclusion. In this cohort, longterm health outcomes, as well as treatments and health care utilization, were similar among persons with RA who were treated in managed care and fee-for-service practice settings.

AB - Objective. To compare health care utilization and longterm health outcomes among patients with rheumatoid arthritis (RA) treated in managed care and fee-for-service practice settings. Methods. We compared levels of health care utilization, treatments, and health outcomes between 57 patients with RA treated predominantly in managed care settings and 125 patients with RA treated predominantly in fee-for-service practice settings. These patients were participants in a community based cohort study of health outcomes in RA, and had been followed prospectively for up to 13 years (mean follow-up 10.3 yrs). Information on physician visits, hospitalizations, diagnostic testing, treatments, and 3 measures of health status (global arthritis status, pain, functional disability measures of the Health Assessment Questionnaire) was collected using biannual mailed questionnaires. Results. All measures of health care utilization were similar between the managed care and fee-for- service groups, as was the use of the major types of arthritis treatments. Average global arthritis status scores, pain scores, and functional disability scores were closely comparable in the 2 groups. Over time, global arthritis status scores and disability scores worsened in both groups, but the rates of worsening did not differ between groups. Conclusion. In this cohort, longterm health outcomes, as well as treatments and health care utilization, were similar among persons with RA who were treated in managed care and fee-for-service practice settings.

KW - Managed care

KW - Quality of care

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0031946577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031946577&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 641

EP - 649

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 4

ER -